ArticleScience translational medicine2014

Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice.

Amy Brock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.